Contemporary European Practice in Left Atrial Appendage Closure: Results from a Survey Focusing on Planning, Techniques and Post-implantation Management

Overview

Journal BMJ Open

Specialty General Medicine

Date 2025 Feb 19

PMID 39971606

Authors

Philippe Garot

Jens-Erik Nielsen-Kudsk

Xavier Freixa

Sergio Berti

Nina Wunderlich

Ignacio Cruz-Gonzalez

Lorenz Raber

Adel Aminian

Ole De Backer

Affiliations

Soon will be listed here.

Abstract

Objectives: The purpose of this European survey was to describe current preprocedural planning, procedure techniques and post-implantation management of left atrial appendage closure (LAAC).

Design: Prospective survey regarding current practice for LAAC between March and August 2023.

Setting: 357 participating European LAAC centres in 14 countries.

Results: In 2022, the participating centres performed a total number of 9447 LAAC procedures, with a mean of 26 LAAC cases per centre (median 20; IQR 10-35). Preprocedure planning was performed with transoesophageal echocardiography (TOE) in 63% of centres, cardiac CT in 16%, or both in 21%. LAAC procedures were performed under general anaesthesia (59%), conscious sedation (36%) or with local anaesthesia only (5%). Device implantation was guided by conventional TOE (94%), intracardiac echocardiography (6%), miniaturised TOE probes (4%) or CT/fluoroscopy fusion (2%). The standard post-procedural antithrombotic regimen was dual antiplatelet therapy (73%), followed by single antiplatelet therapy (18%), conventional dose direct oral anticoagulant (DOAC) (7%) or half dose DOAC (1%), and no antithrombotic treatment (1%). There was a large heterogeneity between regions in terms of procedure volumes, hospital organisation, preprocedural planning, as well as procedural techniques and post-procedure management.

Conclusions: The present survey indicates that LAAC has become a widespread procedure in Europe. The findings highlight considerable heterogeneity among European countries in terms of preprocedural planning, procedural techniques including guidance and the post-procedural antithrombotic regimen. There is a need to evaluate the outcomes of different practices.

References

De Backer O, Iriart X, Kefer J, Nielsen-Kudsk J, Aminian A, Rosseel L . Impact of Computational Modeling on Transcatheter Left Atrial Appendage Closure Efficiency and Outcomes. JACC Cardiovasc Interv. 2023; 16(6):655-666. DOI: 10.1016/j.jcin.2023.01.008. View

Wang D, Eng M, Kupsky D, Myers E, Forbes M, Rahman M . Application of 3-Dimensional Computed Tomographic Image Guidance to WATCHMAN Implantation and Impact on Early Operator Learning Curve: Single-Center Experience. JACC Cardiovasc Interv. 2016; 9(22):2329-2340. DOI: 10.1016/j.jcin.2016.07.038. View

Korsholm K, Samaras A, Andersen A, Jensen J, Nielsen-Kudsk J . The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation. JACC Clin Electrophysiol. 2020; 6(13):1633-1642. DOI: 10.1016/j.jacep.2020.06.028. View

Korsholm K, Berti S, Iriart X, Saw J, Wang D, Cochet H . Expert Recommendations on Cardiac Computed Tomography for Planning Transcatheter Left Atrial Appendage Occlusion. JACC Cardiovasc Interv. 2019; 13(3):277-292. DOI: 10.1016/j.jcin.2019.08.054. View

Leipsic J, Gurvitch R, LaBounty T, Min J, Wood D, Johnson M . Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging. 2011; 4(4):416-29. DOI: 10.1016/j.jcmg.2011.01.014. View

ONeill B, Wang D . Pre-CT Planning in LAAO: Time to Pass the Probe. JACC Cardiovasc Interv. 2023; 16(11):1344-1346. DOI: 10.1016/j.jcin.2023.03.050. View

Wang Y, Di Biase L, Horton R, Nguyen T, Morhanty P, Natale A . Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol. 2010; 21(9):973-82. DOI: 10.1111/j.1540-8167.2010.01814.x. View

Zhang L, Cong T, Liu A . Percutaneous closure of the left atrial appendage: The value of real time 3D transesophageal echocardiography and the intraoperative change in the size of the left atrial appendage. Echocardiography. 2019; 36(3):537-545. DOI: 10.1111/echo.14262. View

Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E . 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023; 83(1):109-279. PMC: 11104284. DOI: 10.1016/j.jacc.2023.08.017. View

10.

Hassan A, Alkhouli M, Thaden J, Guerrero M . 3D Intracardiac Echo-Guided Transseptal Mitral Valve-in-Valve Under Conscious Sedation: Minimalistic Approach TMVR for Same-Day Discharge. JACC Cardiovasc Interv. 2022; 15(9):e103-e105. DOI: 10.1016/j.jcin.2022.02.016. View

11.

Galea R, Aminian A, Meneveau N, De Marco F, Heg D, Anselme F . Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success: A Swiss-Apero Trial Subanalysis. JACC Cardiovasc Interv. 2023; 16(11):1332-1343. DOI: 10.1016/j.jcin.2023.02.027. View

12.

Nielsen-Kudsk J, Berti S, De Backer O, Aguirre D, Fassini G, Cruz-Gonzalez I . Use of Intracardiac Compared With Transesophageal Echocardiography for Left Atrial Appendage Occlusion in the Amulet Observational Study. JACC Cardiovasc Interv. 2019; 12(11):1030-1039. DOI: 10.1016/j.jcin.2019.04.035. View

13.

Khan J, Parmar M, Bhamare A, Agarwal S, Khosla J, Liu B . Same-day discharge for left atrial appendage occlusion procedure: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023; 34(5):1196-1205. DOI: 10.1111/jce.15914. View

14.

Tan B, Boppana L, Abdullah A, Chuprun D, Shah A, Rao M . Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure With the WATCHMAN Device. Circ Cardiovasc Interv. 2021; 14(1):e009669. PMC: 7813443. DOI: 10.1161/CIRCINTERVENTIONS.120.009669. View

15.

Aminian A, Leduc N, Freixa X, Swaans M, Ben Yedder M, Maarse M . Left Atrial Appendage Occlusion Under Miniaturized Transesophageal Echocardiographic Guidance and Conscious Sedation: Multicenter European Experience. JACC Cardiovasc Interv. 2023; 16(15):1889-1898. DOI: 10.1016/j.jcin.2023.06.007. View

16.

Velagapudi P, Turagam M, Kolte D, Khera S, Gupta T, Garg J . Intracardiac vs transesophageal echocardiography for percutaneous left atrial appendage occlusion: A meta-analysis. J Cardiovasc Electrophysiol. 2018; 30(4):461-467. DOI: 10.1111/jce.13820. View

17.

Tilz R, Potpara T, Chen J, Dobreanu D, Larsen T, Haugaa K . Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey. Europace. 2017; 19(10):1737-1742. DOI: 10.1093/europace/eux254. View

18.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial.... Eur Heart J. 2021; 42(40):4194. DOI: 10.1093/eurheartj/ehab648. View

19.

Price M, Slotwiner D, Du C, Freeman J, Turi Z, Rammohan C . Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States. JACC Cardiovasc Interv. 2022; 15(7):741-750. PMC: 9116488. DOI: 10.1016/j.jcin.2022.02.009. View

20.

Holmes Jr D, Doshi S, Kar S, Price M, Sanchez J, Sievert H . Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. J Am Coll Cardiol. 2015; 65(24):2614-2623. DOI: 10.1016/j.jacc.2015.04.025. View